Lee Jeffrey Gene 4
4 · BlackRock Health Sciences Trust · Filed Feb 2, 2022
Insider Transaction Report
Form 4
Lee Jeffrey Gene
Other
Transactions
- Disposition to Issuer
Common Stock
2022-01-31$45.10/sh−71.445$3,222→ 0 total - Exercise/Conversion
Common Stock
2022-01-31+71.445→ 71.445 total - Award
Phantom Shares
2022-01-31$45.10/sh+363.775$16,406→ 363.775 total→ Common Stock (363.775 underlying) - Exercise/Conversion
Phantom Shares
2022-01-31−71.445→ 142.89 total→ Common Stock (71.445 underlying)
Footnotes (3)
- [F1]A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash.
- [F2]As previously reported on a Form 4 dated February 2, 2021, the Reporting Person was granted phantom shares on January 29, 2021 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
- [F3]These phantom shares vest in equal installments on each of the first three anniversaries of the award.